Nucleotide (GenBank) : AX109602 Sequence 335 from Patent WO0123604.

Nucleotide (GenBank) : AX111042 Sequence 1775 from Patent WO0123604.

Nucleotide (GenBank) : U12780 Proteus vulgaris rtn gene, complete cds.

Nucleotide (GenBank) : L04163 Proteus vulgaris PvuI endonuclease gene, 3' end.

Nucleotide (GenBank) : X52681 Proteus vulgaris plasmid gene for PvuII restriction enzyme.

Nucleotide (GenBank) : X13778 Proteus vulgaris plasmid-encoded gene pvuIIM for PvuII DNA-(cytosine-N4)-methyltransferase.

Nucleotide (GenBank) : L01758 Proteus vulgaris partial macromolecular synthesis (MMS) operon; rpsU gene, 3' end, and primase (dnaG) gene, 5' end.

Stolle RJ, Beck LR. Prevention and treatment of rheumatoid arthritis. US Patent 4,732,757 dated Mar 22 1988

Opinion 26. Designation of neotype strains (cultures) of type species of the bacterial genera Salmonella, Shigella Arizona, Escherichia, Citobacter, and Proteus of the family Enterobacteriaceae. Int. Bull. Bacteriol. Nomencl. Taxon. 13: 35-36, 1963.

Ackrell BA, et al. Multiple forms of bacterial hydrogenases. J. Bacteriol. 92: 828-838, 1966. PubMed: 5926752

. . J. Gen. Microbiol. 38: 417-422, 1965.

Gingeras TR, et al. Two new restriction endonucleases from Proteus vulgaris. Nucleic Acids Res. 9: 4525-4536, 1981. PubMed: 6272209